Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical Advances in Hematology & OncologyHighlights in Graft-vs-Host Disease From the 2021 Transplantation & Cellular Therapy (TCT) Meetings of the ASTCT and the CIBMTR

From the pages of Clinical Advances in Hematology & Oncology comes this review of selected presentations from the 2021 TCT Meetings Digital Experience, which took place February 8-12, 2021. Expert commentary is provided by Dr. Yi-Bin Chen, Director of the Hematopoietic Cell Transplant & Cellular Therapy Program at Massachusetts General Hospital.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form